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Abstract: In the reaction of ZnCl2 with tacrine hydrochloride in water novel 
tetracoordinated (C13H15N2)2[ZnCl4]⋅H2O complex was obtained and charac-
terized by elemental analysis, molar conductivity and X-ray analysis. The com-
plex crystallizes in the space group P−1 of the triclinic crystal system. The 
structure contains two crystallographically different molecules of protonated 
tacrine present as counter cations, the [ZnCl4]2- complex anion and one water 
solvent molecule. The counter cations slightly differ in the puckering of the 
cyclohexene ring. The molecules of protonated tacrine are involved in different 
intermolecular hydrogen bonds. In the crystal, the hydrogen bonding generates 
a 3D assembly. In the crystal, π⋅⋅⋅π stacking interactions between the rings of 
protonated tacrine were evidenced. The [ZnCl4]2- complex anion has a dis-
torted tetrahedral geometry. Three out of the four Cl atoms are involved in 
intermolecular hydrogen bonding. The intermolecular H-bond interactions in-
volving the Cl atoms affect the Zn–Cl bond lengths. 
Keywords: Zinc; tacrine; X-ray analysis. 
INTRODUCTION 
Alzheimer’s disease (AD) is a late-onset and the most common form of de-
mentia affecting one in ten people over the age of 65 and one out of every two 
people over the age of 80. Symptoms include memory loss, anxiety, aggression, 
delusion, disorientation and loss of intellectual facilities, including cognition and 
eventually loss of physiological functions due to the advancing dementia.1 Both 
genetic and environmental factors are implicated in its development.2 
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The major hypothesis as to the cause of AD relates to the deposition in the 
brain of a peptide termed β-amyloid (Aβ).1 β-Amyloid fragments can polymerize 
to form what are referred to as “plaques”.3 
It is well known that the brain contains large amounts of metals (Cu(II), 
Zn(II) and Fe(III)).4 High levels of zinc, copper and iron are constitutively found 
in the neocortical regions which are most prone to AD pathology.2 Although 
Zn(II), Cu(II) and Fe(III) play important roles in cortical physiology, only Cu(II) 
and Zn(II) are released during neurotransmission.4,5 These metal ions interact 
with the amyloid precursor protein (APP) and Aβ.6–8 Recently, research of cop-
per/zinc chelators as inhibitors of Aβ accumulation was initiated.9,10 
It is well known that many neurotransmitter systems are implicated in the 
etiology of AD; a cholinergic deficit having been clearly established. In addition, 
there is a decrease of choline acetyltransferase activity.2 In the last two decades, 
various cholinergic drugs, primarily inhibitors of the enzyme acetylcholineste-
rase, such as tacrine, donepezil, rivastigmin and galantamin, are used in the medi-
cal treatment of AD patients.11,12 Tacrine is a drug that is used to treat the 
symptoms of mild to moderate Alzheimer’s disease. The drug retards the break-
down of acetylcholine; hence, it can build up and have a greater effect. It can 
improve thinking ability in some patients with AD. Bearing in mind that tacrine 
(Scheme 1) is widely used in the treatment of AD and that zinc is related to AD, 
it was considered interesting to investigate the possibilities of coordination of 
tacrine with Zn(II). 
Scheme 1. Structure of tacrine. 
EXPERIMENTAL 
Synthesis of (C13H15N2)2[ZnCl4]·H2O (1) 
A solution of 0.068 g (0.50 mmol) ZnCl2 in 5 cm3 of water was added to a suspension of 
0.234 g (1.0 mmol) tacrine hydrochloride (C13H14N2·HCl) in 15 cm3 acetonitrile–water (9:1). 
The mixture was refluxed for 2.5 h (60 °C). The resulting solution was cooled to room tem-
perature and after 16 h, a white microcrystalline product was obtained.  
Synthesis of C13H14N2·2H2O (2) 
An analogous reaction was performed using Na2[Zn(OH)4] and tacrine hydrochloride 
whereby tacrine dihydrate was obtained. Yield: 40%. 
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Physical measurements 
Elemental analyses were performed using an Elemental Vario EL III microanalyser. The 
molar conductivity of an aqueous solution of the complex (1.0×10-3 mol dm-3) was measured 
at room temperature on a Jenway-4009 digital conductivity meter. 
X-Ray analysis 
The single crystal X-ray data for compound 1 were collected on an Enraf-Nonius CAD-4 
diffractometer13 using Mo Kα radiation (λ = 0.71073 Å) and ω/2θ scans in the 1.74 to 26.00° 
θ range. The cell constants and an orientation matrix for data collection, obtained from 24 
centered reflections in the θ range 12.01 to 15.81° corresponded to a triclinic cell. The data 
were corrected for Lorentz and polarization effects.14 The crystal structure was solved by di-
rect methods15 and difference Fourier methods, and refined on F2 by the full-matrix least- 
-square method.16 All six hydrogen atoms bonded to nitrogen atoms (N1a, N1b, N2a and N2b) 
as well as the two H atoms from the water molecule were taken from the ΔF map and refined 
isotropically. This treatment of H atoms resulted in unrealistically short X–H distances for 
some of the X–H (X = O,N) bonds. Due to this, all H atoms were included in the refinement at 
their geometrically calculated positions and treated with a riding model. Anisotropic displa-
cement parameters were refined for all non-hydrogen atoms. PLATON,17,18, WinGX,19 
PARST,20 ORTEPIII21 and Mercury22 software were used for the preparation of the crystal-
lographic materials for publication. 
RESULTS AND DISCUSSION 
Compound 1 was obtained in the reaction of aqueous solutions of ZnCl2 and 
tacrine hydrochloride in the molar ratio 1:2 (yield: 142 mg (45 %)). 
Elemental analysis of compound 1. C, 49.77, H, 5.50, N, 8.98 % corresponds 
to C26H32Cl4N4OZn (FW = 623.77); Calcd.: C, 50.04; H, 5.18; N 8.98 %. The 
result of the molar conductivity of compound 1 (λM = 252 Ω-1 cm2 mol-1 (H2O, 
1.0×10-3 mol dm-3) is in agreement with a 2:1 electrolyte type. 
Compound 2 was obtained by the same procedure as employed for 1 but 
starting from Na2[Zn(OH)4]. Elemental analysis of 2 showed it to be tacrine 
which had crystallized as the dihydrate. Anal. Calcd. for C13H18N2O2: (FW = 
234.3): C, 66.64; H, 6.02; N 11.96 %. Found: C, 66.28, H, 5.50, N, 12.05 %. 
Crystal data of 1. C26H32Cl4N4OZn; crystal system, triclinic; space group, 
P–1; unit cell dimensions: a = 9.972(3) Å, b = 11.843(3) Å, c = 12.626(3) Å, α = 
= 76.61(2)°, β = 72.32(3)°, γ = 87.10(3)°, V = 1381.7(6) Å3; Z = 2; ρc = 1.499 
mg m–3; μ = 1.303 mm–1; reflections collected, 5750; independent reflections, 
5421 (Rint = 0.0218); final R indices (I > 2σ(I)), R1 = 0.0647, wR2 = 0.1629 (for 
325 refined parameters); goodness-of-fit, 0.978. 
The results of the single crystal X-ray analysis of 1 revealed that in the re-
action of ZnCl2 with tacrine, the more stable tetrachlorozincate(II) complex was 
obtained in which protonated tacrine (C13H15N2+) serves as a counter cation 
(Fig. 1). This is the first structure of a typical complex compound with proto-
nated tacrine as a counter ion. Only two crystal structures: (C13H15N2Cl·H2O, 
CSD refcode GICMEK01, and C13H15N2[B(Ph)4]·CH3CN, CSD refcode 
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GOLFIW), containing protonated tacrine (C13H15N2+) were found in the Camb-
ridge Structural Database (CSD).23 Both of them are structures of salts of proto-
nated tacrine. In the crystal structures of C13H15N2Cl·H2O (GICMEK01)24 and 
C13H15N2[B(Ph)4]·CH3CN (GOLFIW),25 two and four C-atoms in the cyclohe-
xenyl ring, respectively, are disordered. In the crystal structure of compound 1, 
positional disorder was not observed. The crystal structure of 1 contains two dif-
ferent molecules of protonated tacrine (C13H15N2+), present as counter cations, 
and [ZnCl4]2–, as a complex anion, i.e., two crystallographically independent 
molecules of protonated tacrine (C13H15N2+) and a [ZnCl4]2– complex anion are 
in an asymmetric unit. There is also one molecule of crystal water in the asym-
metric unit. 
 
Fig. 1. The molecular geometry and atom labeling scheme of (C13H15N2)2[ZnCl4]
.H2O (1). 
Selected bond distances (Å): Zn–Cl(1) = 2.282(2), Zn–Cl(2) = 2.232(2), Zn–Cl(3) = 2.293(2), 
Zn–Cl(4) = 2.273(2) and angles (°): Cl(2)–Zn–Cl(4) = 109.13(7), Cl(2)–Zn–Cl(1) = 
= 114.97(7), Cl(4)–Zn–Cl(1) = 109.57(7), Cl(2)–Zn–Cl(3) = 111.49(7), 
Cl(4)–Zn–Cl(3) = 105.54(7), Cl(1)–Zn–Cl(3) = 105.70(7). 
The cation molecules (labeled as A and B) are comparable in terms of con-
formational and geometrical parameters (bond lengths and angles) except in the 
position of the C(12) atom (from the C(12)H2 group) that is out of plane in the 
case of the protonated tacrine A. The displacement from the mean plane of the 
C(8)–C(9)–C(10)–C(11)–(C13) fragment in the case of C(12a) is 0.58(1) Å (in 
the case of the protonated tacrine B, such a displacement is not significant, 
0.02(1) Å for the C(12b) atom). Two molecules of protonated tacrine (A and B) 
form different H-bonds (Table I, Fig. 2). The most obvious difference is in the 
case of the pyridinium nitrogen [N(2)], which in molecule A forms a hydrogen 
bond with a water oxygen atom, while in molecule B it forms a weak H-bond 
with a chloride from [ZnCl4]2–. In addition, the amino group of cation A acts as a 
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single hydrogen bond donor, while that of cation B acts as a double hydrogen 
bond donor (vide infra). The solvent water molecule [O(1w)] serves as a double 
donor (to Cl(3) and Cl(3) at –x+2,–y+2,–z) and a single acceptor which is com-
mon for a water molecule. The chloride atoms (Cl(3) and Cl(3) at –x+2,–y+2,–z) 
help in completing the water rings around the centre of inversion at 0 0 0. The 
system of H-bond interactions spreads in three-dimensions. In the crystal pack-
ing, π-stacking interactions between the rings of protonated tacrine molecules 
occur. For example, the mean planes of the pyridinium rings are approximately 
parallel and they are at a distance of about 3.5 Å from each other. The cation mo-
lecules are stacked in the ⋅⋅⋅A–A–B–B–A–A–⋅⋅⋅ order (Fig. 2).  
TABLE I. The geometry of hydrogen bonding and selected intermolecular interactions (Å and 
°, respectively) for compound 1. Symmetry codes: i) x,y,z; ii) x–1,y,z; iii) –x+1,–y+1,–z; 
iv) –x+2,–y+2,–z; v) –x+1,–y+1,–z+1; vi) x,y–1,z 
D–H⋅⋅⋅A D–H D⋅⋅⋅A H⋅⋅⋅A D–H–A 
N(2b)–H(2n2)⋅⋅⋅Cl(1)i 0.86 3.318(5) 2.49 162 
N(1b)–H(1b)⋅⋅⋅Cl(1)ii 0.86 3.483(5) 2.70 153 
N(1b)–H(2b)⋅⋅⋅Cl(3)iii 0.86 3.433(6) 2.66 149 
O(1w)–H(1w)⋅⋅⋅Cl(3)i 0.85 3.279(5) 2.45 163 
O(1w)–H(2w)⋅⋅⋅Cl(3)iv 0.85 3.379(5) 2.59 155 
N(1a)–H(2a)⋅⋅⋅Cl(4)v 0.86 3.260(6) 2.44 161 
N(2a)–H(1n2)⋅⋅⋅O(1w)vi 0.86 2.772(6) 1.91 175 
For the sake of comparison, the contacts surrounding the cations A and B in 
the present compound, 
C13H15N2Cl·H2O (GICMEK01)24 and 
C13H15N2[B(Ph)4]·CH3CN (GOLFIW)25 
are depicted in Figs. 3–6, respectively. 
In two of the analyzed structures of protonated tacrine (cation B and 
GICMEK01), both hydrogen atoms from the amino group are involved in hyd-
rogen bonding with chloride atoms. In the case of cation A, only one amine hyd-
rogen is involved in NH⋅⋅⋅Cl hydrogen bonding. In the former cases, the inter-
molecular N–H⋅⋅⋅Cl bonds are more bent and weaker than in the latter one. In the 
crystal structure of C13H15N2[B(Ph)4]·CH3CN (GOLFIW), one amine hydrogen 
is directional towards the phenyl group at the symmetry position 1–x, 1–y, 1–z. 
This hydrogen is engaged in weak N–H⋅⋅⋅π (Ph) hydrogen bonding. The shortest 
N–H⋅⋅⋅C distance is 2.75 Å. In all the analyzed structures, the amino group is 
nearly coplanar with the aromatic ring system. The dihedral angle between the 
plane defined by the amino group and the plane defined by the aromatic ring sys-
tem range from 1.6(6) to 8.6(3)°. The pyridinium nitrogen serves as a single hyd-
rogen bond donor in the observed structures. The D–H⋅⋅⋅X angles of the two- 
-centre hydrogen bonds involving pyridinium nitrogen are in the range 162–175°. 
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Fig. 2. The packing diagrams show intermolecular hydrogen bonding and 
π-stacking interactions in the crystal of (1). 
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Fig. 3. The intermolecular contacts involving 
the functional groups of cation A. Symmetry 
codes: v) –x+1, –y+1, –z+1; vi) x, y–1, z. 
 
Fig. 4. The intermolecular contacts involving 
the functional groups of cation B. Symmetry 
codes: i) x, y, z; ii) x–1, y, z; 
iii) –x+1, –y+1, –z. 
 
Fig. 5. The intermolecular contacts involving 
the functional groups of the cation in 
GICMEK01. Symmetry code: 3/2 – x; 1/2 + y; 
1/2 – z. 
The interesting characteristics of the structure are the differences in Zn–Cl 
bond lengths in the [ZnCl4]2– anion: Zn–Cl(2), 2.232(2); Zn–Cl(4), 2.273(2); 
Zn–Cl(1) 2.282(2) and Zn–Cl(3) 2.293(2) Å. The difference between the longest 
[Zn-Cl(3)] and the shortest bond [Zn–Cl(2)] is 0.06 Å. The differences in bond 
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lengths are the result of various H-bonds in which the Cl atoms participate. The 
Cl(3), Cl(1) and Cl(4) atoms serve as triple, double and single hydrogen bond 
acceptor, respectively, while the Cl(2) atom does not form any H-bond. The Zn–Cl 
bond length increases with increasing the number of hydrogen bonds in which 
the Cl atom is involved. The tetrahedral coordination geometry around the Zn 
atom is distorted with Cl–Zn–Cl coordination angles in the range from 105.54(7) 
to 114.97(7)°. These structural differences could also be explained by intermole-
cular interactions with involvement of the Cl atoms. 
Fig. 6. The intermolecular contacts involving the func-
tional groups of the cation in GOLFIW. 
CONCLUSIONS 
The (C13H15N2)2[ZnCl4]·H2O complex of distorted tetrahedral geometry 
was obtained in the reaction of ZnCl2 with tacrine hydrochloride. The contacts 
surrounding the cations in the present structure and in the structures of 
C13H15N2Cl·H2O24 and C13H15N2[B(Ph)4]·CH3CN25 reported elsewhere have 
been analyzed in detail. The prominent structural feature of [ZnCl4]2– is the va-
riation in the Zn–Cl bond lengths. The Zn–Cl bond length increases with increas-
ing the number of intermolecular hydrogen bonds that involve the ligand atom. 
Supplementary data. Cambridge Crystallographic Data Center, CCDC No. 695064, con-
tains the supplementary crystallographic data for this paper. These data can be obtained free 
of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the CCDC, 12 Union 
Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033; e-mail: deposit@ccdc.cam.ac.uk).  
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И З В О Д  
СИНТЕЗА И КРИСТАЛНА СТРУКТУРА 1,2,3,4-ТЕТРАХИДРО-9-АМИНОАКРИДИН- 
-ТЕТРАХЛОРОЦИНКАТА(II) МОНОХИДРАТА 
ЂЕНАНА У. МИОДРАГОВИЋ1, ДРАГОЉУБ ЈОВАНОВИЋ2, ГОРАН А. БОГДАНОВИЋ3, 
ДРАГАНА МИТИЋ1 и КАТАРИНА АНДЈЕЛКОВИЋ1 
1Hemijski fakultet, Univerzitet u Beogradu, p. pr. 158, 11001 Beograd, 2Катедра za ishranu i botaniku,  
Фakultet ветеринарске медицине, Univerzitet u Beogradu, Bulevar oslobo|ewa 18, Beograd i 3Ins-
titut Vin~a, Laboratorija za teorijsku fiziku i fiziku kondenzovane materije, p. pr. 522, 11001 Beograd 
У реакцији ZnCl2 са такрин-хидрохлоридом у води, добијен је нови тетракоординовани 
(C13H15N2)2[ZnCl4]⋅H2О комплекс који је окарактерисан помоћу елементалне анализе, молар-
не проводљивости и рендгенске структурне анализе. Комплекс кристалише у просторној 
групи P−1 триклиничног кристалног система. Структура садржи два кристалографски разли-
чита молекула протонованог такрина који су присутни као контра-катјони, [ZnCl4]2- компле-
ксни анјон и молекул кристалне воде. Молекули катјона се незнатно разликују у степену на-
бирања циклохексеновог прстена. Молекули протонованог такрина су укључени у различите 
интермолекулске водоничне везе. Интермолекулско водонично везивање у кристалу генери-
ше 3Д молекулски скуп; π⋅⋅⋅π интеракције између прстенова протонованог такрина су приме-
ћене у кристалу. [ZnCl4]2- има дисторговану тетраедарску геометрију. Три од четири Cl 
атома су укључена у интермолекулске водоничне везе. Интермолекулске водоничне ин-
теракције које укључују Cl атоме утичу на дужину Zn–Cl веза. 
(Примљено 2. марта, ревидирано 26. априла 2010) 
REFERENCES 
1. H. Kozłowski, D. R. Brown, G. Valensin, Metallochemistry of Neurodegeneration, Biolo-
gical, Chemical and Genetic Aspects, The Royal Society of Chemistry, Cambridge, 2006 
2. R. R. Crichton, R. J. Ward, Metal-based Neurodegeneration: From Molecular Mecha-
nisms to Therapeutic Strategies, Wiley, Chichester, 2006 
3. J. A. Hardz, G. A. Higgins, Science 256 (1992) 184 
4. O. Wirths, G. Multhaup, T. A. Bayer, J. Neurochem. 91 (2004) 513 
5. M. P. Cuajungco, K. Y. Fagét, Brain Res. Rev. 41 (2003) 44 
6. C. S. Atwood , R. D. Moir, X. Huang, R. C. Scarpa, N. Michael, E. Bacarra, D. M. Ro-
mano, M. A. Hartshorn, R. E. Tanzi, A. I. Bush, J. Biol. Chem. 273 (1998) 12817 
7. M. Stoltenberg, A. I. Bush, G. Bach, K. Smidt, A. Larsen, J. Rungby, S. Lund, P. Doer-
ing, G. Danscher, Neuroscience 150 (2007) 357 
8. C. J. Frederickson, A. I. Bush, BioMetals 14 (2001) 353 
9. S. Zirah, S. A. Kozin, A. K. Mazur, A. Blond, M. Cheminant, I. Ségalas-Milazzo, P. De-
bey, S. Rebuffat, J. Biol. Chem. 281 (2006) 2151 
10. X. Huang, C. S. Atwood, M. A. Hartshorn, G. Multhaup, L. E. Goldstein, R. C. Scarpa, 
M. P. Cuajungco, D. N. Gray, J. Lim, R. D. Moir, R. E. Tanzi, A. I. Bush, Biochemistry 
38 (1999) 7609 
11. C. Opazo, X. Huang, R. A. Cherny, R. D. Moir, A. E. Roher, A. R. White, R. Cappai, C. 
L. Masters, R. E. Tanzi, N. C. Inestrosa, A. I. Bush, J. Biol. Chem. 227 (2002) 40302 
_________________________________________________________________________________________________________________________
Available online at www.shd.org.rs/JSCS/
2010 Copyright (CC) SCS
1218 MIODRAGOVIĆ et al. 
12. X. Huang, C. S. Atwood, R. D. Moir, M. A. Hartshorn, J-P. Vonsattel, R. E. Tanzi, A. I. 
Bush, J. Biol. Chem. 272 (1997) 26464 
13. Enraf-Nonius CAD4 Software, version 5.0, Enraf-Nonius, Delft, 1989 
14. CAD-4 Express Software, Enraf-Nonius, Delft, 1994 
15. G. M. Sheldrick, SHELXS97. Program for the Solution of Crystal Structures, University 
of Göttingen, Göttingen, 1997 
16. G. M. Sheldrick, SHELXL97. Program for the Refinement of Crystal Structures, Univer-
sity of Göttingen, Göttingen, 1997 
17. A. L. Spek, Acta Crystallogr. D 65 (2009) 148 
18. A. L. Spek, Platon, A Multipurpose Crystallographic Tool, Utrecht University, Utrecht, 2010 
19. L. J. Farrugia, J. Appl. Crystallogr. 32 (1999) 837 
20. M. Nardelli, J. Appl. Crystallogr. 28 (1995) 659 
21. L. J. Farrugia, J. Appl. Crystallogr. 30 (1997) 565 
22. I. J. Bruno, J. C. Cole, P. R. Edgington, M. Kessler, C. F. Macrae, P. McCabe, J. Pearson, 
R. Taylor, Acta Crystallogr. B 58 (2002) 389 
23. F. H. Allen, Acta Crystallogr. B 58 (2002) 380 
24. G. Bandoli, A. Dolmella, S. Gatto, M. Nicolini, J. Chem. Crystallogr. 24 (1994) 301 
25. K. N. Robertson, P. K. Bakshi, S. D. Lantos, T. S. Cameron, O. Knop, Can. J. Chem. 76 
(1998) 583. 
_________________________________________________________________________________________________________________________
Available online at www.shd.org.rs/JSCS/
2010 Copyright (CC) SCS
